The reduced PML levels lead to a derepression of mammalian target of rapamycin (mTOR), which in turn participates in a feedback mechanism to amplify HIF-1α signaling, thus facilitating tumor progression [107]. This evidence concerns the gene HIF1A and neoplasm.